Anpario (LON:ANP) Shares Up 10.9% – Still a Buy?

Anpario plc (LON:ANPGet Free Report)’s stock price shot up 10.9% during trading on Friday . The company traded as high as GBX 415 ($5.11) and last traded at GBX 407.66 ($5.02). 152,837 shares traded hands during mid-day trading, an increase of 273% from the average session volume of 40,994 shares. The stock had previously closed at GBX 367.50 ($4.52).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group increased their price target on shares of Anpario from GBX 340 ($4.18) to GBX 370 ($4.55) and gave the company a “buy” rating in a report on Wednesday, September 18th.

Get Our Latest Stock Report on ANP

Anpario Trading Up 10.9 %

The company has a debt-to-equity ratio of 0.21, a quick ratio of 5.16 and a current ratio of 6.15. The stock has a market cap of £68.94 million, a P/E ratio of 2,264.78 and a beta of 0.58. The stock’s fifty day moving average is GBX 355.75 and its 200 day moving average is GBX 319.41.

Insider Buying and Selling

In related news, insider Karen Prior sold 14,000 shares of the stock in a transaction dated Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.68), for a total value of £53,200 ($65,460.81). 30.51% of the stock is currently owned by corporate insiders.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Articles

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.